Recent studies have revealed that three blood-based PD-L1 indicators, namely soluble PD-L1 (sPD-L1), exosomal PD-L1 (exoPD-L1), and PD-L1 in circulating tumor cells (CTCs), are linked to prognosis in patients with cancer [20–22]. The gene discussed is CD274; the disease is neoplasm.